These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36549931)

  • 21. Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.
    Hawk KF; Vaca FE; D'Onofrio G
    Yale J Biol Med; 2015 Sep; 88(3):235-45. PubMed ID: 26339206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.
    Walters SM; Baker R; Frank D; Fadanelli M; Rudolph AE; Zule W; Fredericksen RJ; Bolinski R; Sibley AL; Go VF; Ouellet LJ; Pho MT; Seal DW; Feinberg J; Smith G; Young AM; Stopka TJ
    Harm Reduct J; 2024 Aug; 21(1):154. PubMed ID: 39182116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
    Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative examination of naloxone access in three states: Connecticut, Kentucky, and Wisconsin.
    Spector AL; Galletly CL; Christenson EA; Montaque HDG; Dickson-Gomez J
    BMC Public Health; 2022 Jul; 22(1):1387. PubMed ID: 35854278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis.
    Antoniou T; McCormack D; Campbell T; Sutradhar R; Tadrous M; Lum-Wilson N; Leece P; Munro C; Gomes T
    Drug Alcohol Depend; 2020 Nov; 216():108238. PubMed ID: 32891910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.
    Sohn M; Talbert JC; Huang Z; Lofwall MR; Freeman PR
    JAMA Netw Open; 2019 Jun; 2(6):e196215. PubMed ID: 31225895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of paying people who use drugs cash to distribute naloxone within their networks.
    Lewis NM; Smeltzer RP; Baker TJ; Sahovey AC; Baez J; Hensel E; Poole B; Stewart C; Cogan AG; Bullard M; Taylor JL
    Harm Reduct J; 2024 Feb; 21(1):42. PubMed ID: 38365734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs of opioid overdose education and naloxone distribution in New York City.
    Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
    Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
    [No Abstract]   [Full Text] [Related]  

  • 32. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harm Reduction Strategies for the Opiod Crisis.
    Castillo T
    N C Med J; 2018; 79(3):192-194. PubMed ID: 29735629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicaid prescription limits and their implications for naloxone accessibility.
    Roberts AW; Look KA; Trull G; Carpenter DM
    Drug Alcohol Depend; 2021 Jan; 218():108355. PubMed ID: 33309522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
    Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addressing Fear of Negative Consequences of Overdose Response: A Qualitative Study of the Perceptions of Service Industry Workers Who Encounter an Opioid Overdose in an Urban Commercial District in Atlanta, Georgia.
    Febres-Cordero S; Thompson LM; Chalfant OS; Sherman ADF; Winiker AK; Kelly UA; Smith KM
    Workplace Health Saf; 2024 Jun; 72(6):244-252. PubMed ID: 38243156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
    Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
    Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
    Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
    Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV prevention and treatment strategies can help address the overdose crisis.
    Walley AY
    Prev Med; 2015 Nov; 80():37-40. PubMed ID: 25895840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.